Search

  • HOME
  • Search
Original Article
1830
Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
Moon Haeng Hur, Yuri Cho, Do Young Kim, Jae Seung Lee, Gyoung Min Kim, Hyo-Cheol Kim, Dong Hyun Sinn, Dongho Hyun, Han Ah Lee, Yeon Seok Seo, In Joon Lee, Joong-Won Park, Yoon Jun Kim
Clin Mol Hepatol. 2023;29(3):763-778.   Published online May 30, 2023
View: 2655   Download: 177  Crossref: 1
Editorial
Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
Sojung Han, Do Young Kim
Clin Mol Hepatol. 2020;26(3):305-308.   Published online July 1, 2020
View: 4138   Download: 108  Web of Science: 5  Crossref: 5
Review
1495
Switching to systemic therapy after locoregional treatment failure: Definition and best timing
Sadahisa Ogasawara, Yoshihiko Ooka, Keisuke Koroki, Susumu Maruta, Hiroaki Kanzaki, Kengo Kanayama, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Eiichiro Suzuki, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Jun Kato, Naoya Kato
Clin Mol Hepatol. 2020;26(2):155-162.   Published online January 15, 2020
View: 9667   Download: 408  Web of Science: 41  Crossref: 38
Original Article
Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line
Ankita Makol, Harpreet Kaur, Sakshi Sharma, Shruthi Kanthaje, Ramanpreet Kaur, Anuradha Chakraborti
Clin Mol Hepatol. 2020;26(1):45-53.   Published online September 30, 2019
View: 7576   Download: 249  Web of Science: 17  Crossref: 14
Case Report
Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive review
Tae Suk Kim, Ji Hoon Kim, Baek hui Kim, Young-Sun Lee, Yang Jae Yoo, Seong Hee Kang, Sang-June Suh, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
Clin Mol Hepatol. 2017;23(4):340-346.   Published online June 20, 2017
View: 15988   Download: 198  Web of Science: 18  Crossref: 18
Original Article
1357
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, Bohyun Jang, Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, Angelo Lozada, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clin Mol Hepatol. 2017;23(2):128-137.   Published online May 10, 2017
View: 11399   Download: 190  Web of Science: 24  Crossref: 21
Editorial
Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
Do Young Kim
Clin Mol Hepatol. 2017;23(2):123-124.   Published online June 23, 2017
View: 6737   Download: 118
Original Article
1285
Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee
Clin Mol Hepatol. 2016;22(1):160-167.   Published online March 28, 2016
View: 11131   Download: 195  Web of Science: 79  Crossref: 69
Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells
Ha Ra Gu, Su Cheol Park, Su Jin Choi, Jae Cheol Lee, You Cheoul Kim, Chul Ju Han, Jin Kim, Ki Young Yang, Yeon Joo Kim, Geum Youb Noh, So Hyeon No, Jae-Hoon Jeong
Clin Mol Hepatol. 2015;21(1):49-59.   Published online March 25, 2015
View: 11609   Download: 121  Web of Science: 29  Crossref: 28
Liver Imaging
Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib
Joon-Il Choi, David K Imagawa, Priya Bhosale, Puneet Bhargava, Temel Tirkes, Tara E Seery, Chandana Lall
Clin Mol Hepatol. 2014;20(2):218-222.   Published online June 30, 2014
View: 6391   Download: 78  Web of Science: 11  Crossref: 12
The Korean Journal of Hepatology Elsewhere
The effect of sorafenib on hepatic stellate cells: implication of its effect on tumor microenvironment
Jung Il Lee
Clin Mol Hepatol. 2010;16(4):418-419.   Published online December 31, 2010
View: 4498   Download: 45  Crossref: 1
2
Molecular targeting for treatment of advanced hepatocellular carcinoma
Il Han Song
Clin Mol Hepatol. 2009;15(3):299-308.   Published online September 30, 2009
View: 5425   Download: 36  Crossref: 6
7
The Korean Journal of Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma
Jeong Heo
Clin Mol Hepatol. 2009;15(2):227-230.   Published online June 30, 2009
View: 3867   Download: 26  Crossref: 1
The Korean Journal of The Efficacy of Sorafenib for Patients With Advanced Hepatocellular Carcinoma
Jeong Heo
Clin Mol Hepatol. 2007;13(4):576-580.   Published online December 20, 2007
View: 3126   Download: 15
Original Article
Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after Atezolizumab/Bevacizumab Failure: A real-world study
Young Eun Chon, Dong Yun Kim, Mina Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Yeonjung Ha, Joo Ho Lee, Kwan Sik Lee, Beodeul Kang, Jung Sun Kim, Hong Jae Chon, Do Young Kim
Received December 21, 2023  Accepted March 8, 2024  
View: 565   Download: 101
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 703
TOTAL : 1773478
Close layer